Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Tides USA 2023 Oligonucleotide & Peptide Therapeutic

Events
Tides 2023G2B

We are back from the west coast, San Diego, from attending Tides USA– Oligonucleotide & Peptide Therapeutics. A renowned event that provides case studies of cutting-edge scientific advances and strategies for accelerating Oligo and Peptide Therapeutics to market.

Our CEO, Meritxell Teixido, was given the chance to participate in one of the event sessions in order to present “Gate2Brain Blood-Brain Barrier Shuttle Peptides, From Discovery to Applications” and Gate2Brain’s advisor and Professor at the University of KwaZulu-Natal and the University of Barcelona, Fernando Albericio, delivered a presentation on “Solvents, the Key Parameter for Greening Solid-Phase Peptide Synthesis”

Attending the TIDES has been a great opportunity to stay up-to-date with the latest developments, to establish new connections, to enhance our learning, and become acquainted with innovative ideas, approaches, and innovations in the field.

Intense and extraordinary days where we had the pleasure to capture up and share with ancient companions and colleagues while meeting new ones! And last but not least, a delightful chance to take a leisurely walk along the beach in San Diego.

May 16, 2023/by noticias
Tags: peptides, Tides2023
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/05/Amarillo-Beis-Rosa-Mujer-Pop-Elemento-Contratacion-Anuncio-No-Estatico-Publicacion-de-LinkedIn.png 1200 1200 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2023-05-16 16:50:042023-05-16 16:50:04Tides USA 2023 Oligonucleotide & Peptide Therapeutic
You might also like
Back to Work with Peptides
Amphiphilic Polymeric Nanoparticles Modified with Protease-Resistant Peptide Shuttle for the Delivery of SN-38 in Diffuse Intrinsic Pontine Glioma
Imitating nature to improve health
New Trends in Brain Shuttle Peptides
Gate2Brain: the startup that delivers drugs to the brain to treat childhood cancer with no cure
Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain
GORDON CONFERENCESgate2brainGordon Research Conferences
17th China International Peptide Academic Symposium17th China International Peptide Academic Symposium

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gate2Brain finalist of the South Summit Madridgate2brain finalist south summit 2023south summitGate2Brain among the 5 Catalan startups that have obtained funding from EIC AcceleratorcanvaGate2Brain among the 5 Catalan startups that have obtained funding from EIC...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}